ProCE Banner Activity

Choosing Frontline Therapy in Chronic Lymphocytic Leukemia

Slideset Download
Download this slideset for expert perspectives on best practices in treating patients with newly diagnosed CLL.

Released: March 04, 2022

Expiration: March 03, 2023

No longer available for credit.

Share

Faculty

Jennifer Woyach

Jennifer Woyach, MD

D Warren Brown Professor of Leukemia Research
Section Head, CLL and Hairy Cell Leukemia
Associate Division Director for Clinical Research
Division of Hematology
Co-Leader Leukemia Research Program
The Ohio State University Comprehensive Cancer Center
Columbus, Ohio

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by educational grants from

AbbVie Inc.

AstraZeneca

Eli Lilly

Janssen Biotech

Pharmacyclics an AbbVie Company

TG Therapeutics

Partners

CLL Society

ProCE Banner

Faculty Disclosure

Primary Author

Jennifer Woyach, MD

D Warren Brown Professor of Leukemia Research
Section Head, CLL and Hairy Cell Leukemia
Associate Division Director for Clinical Research
Division of Hematology
Co-Leader Leukemia Research Program
The Ohio State University Comprehensive Cancer Center
Columbus, Ohio

Jennifer Woyach, MD, has disclosed that she has received funds for research support from AbbVie, Karyopharm, Loxo, Morphosys, and Verastem and consulting fees from AbbVie, Arqule, AstraZeneca, BeiGene, Janssen, Morphosys, and Pharmacyclics.